SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-24-038561
Filing Date
2024-09-27
Accepted
2024-09-27 16:47:33
Documents
6
Period of Report
2024-09-27

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 621929
2 formper14a_001.jpg GRAPHIC 325638
3 formper14a_002.jpg GRAPHIC 273035
4 formper14a_003.jpg GRAPHIC 237725
5 proxycard_001.jpg GRAPHIC 3062168
6 proxycard_002.jpg GRAPHIC 1759345
  Complete submission text file 0001493152-24-038561.txt   8397450
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-11460 | Film No.: 241335608
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)